These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10093866)

  • 1. Sense and nonsense: an essay on schizophrenia research ethics.
    Carpenter WT; Conley RR
    Schizophr Res; 1999 Feb; 35(3):219-25; discussion 227-36. PubMed ID: 10093866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decisional capacity for informed consent in schizophrenia research.
    Carpenter WT; Gold JM; Lahti AC; Queern CA; Conley RR; Bartko JJ; Kovnick J; Appelbaum PS
    Arch Gen Psychiatry; 2000 Jun; 57(6):533-8. PubMed ID: 10839330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The call of the sirens. Navigating the ethics of medication-free research in schizophrenia.
    Fins JJ; Miller FG
    Arch Gen Psychiatry; 1997 May; 54(5):415-6. PubMed ID: 9152094
    [No Abstract]   [Full Text] [Related]  

  • 4. The rationale and ethics of medication-free research in schizophrenia.
    Carpenter WT; Schooler NR; Kane JM
    Arch Gen Psychiatry; 1997 May; 54(5):401-7. PubMed ID: 9152092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent in medication-free schizophrenia research.
    Moser DJ; Reese RL; Schultz SK; Benjamin ML; Arndt S; Fleming FW; Andreasen NC
    Am J Psychiatry; 2005 Jun; 162(6):1209-11. PubMed ID: 15930073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled studies in schizophrenia--ethical and scientific perspectives: an overview of conference proceedings.
    Zipursky RB; Darby P
    Schizophr Res; 1999 Feb; 35(3):189-200. PubMed ID: 10093863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent in psychiatric research: preliminary findings from an ongoing investigation.
    Benson PR; Roth LH; Winslade WJ
    Soc Sci Med; 1985; 20(12):1331-41. PubMed ID: 2862705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity to consent to research in schizophrenia: the expanding evidence base.
    Dunn LB
    Behav Sci Law; 2006; 24(4):431-45. PubMed ID: 16883608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
    Kim SY; Cox C; Caine ED
    Am J Psychiatry; 2002 May; 159(5):797-802. PubMed ID: 11986134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advance directives for subjects of research who have fluctuating cognitive impairments due to psychotic disorders (such as schizophrenia).
    Backlar P
    Community Ment Health J; 1998 Jun; 34(3):229-40. PubMed ID: 9607160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues.
    Brabbins C; Butler J; Bentall R
    Br J Psychiatry; 1996 May; 168(5):540-4. PubMed ID: 8733791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on ethics of drug discontinuation studies in schizophrenia.
    Neylan TC; Wright BA; Shelton MD; van Kammen DP
    Arch Gen Psychiatry; 1990 Feb; 47(2):192. PubMed ID: 1967928
    [No Abstract]   [Full Text] [Related]  

  • 14. The schizophrenia ketamine challenge study debate.
    Carpenter WT
    Biol Psychiatry; 1999 Oct; 46(8):1081-91. PubMed ID: 10536744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competency to consent to research: a psychiatric overview.
    Appelbaum PS; Roth LH
    Arch Gen Psychiatry; 1982 Aug; 39(8):951-8. PubMed ID: 7103684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Wu BJ; Liao HY; Chen HK; Lan TH
    Psychiatry Res; 2016 Mar; 237():323-30. PubMed ID: 26847945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respecting the autonomy of chronic mentally ill women in decisions about contraception.
    Coverdale JH; Bayer TL; McCullough LB; Chervenak FA
    Hosp Community Psychiatry; 1993 Jul; 44(7):671-4. PubMed ID: 8354506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia research participants' responses to protocol safeguards: recruitment, consent, and debriefing.
    Roberts LW; Warner TD; Anderson CT; Smithpeter MV; Rogers MK
    Schizophr Res; 2004 Apr; 67(2-3):283-91. PubMed ID: 14984889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical and human-rights issues in research on mental disorders that may affect decision-making capacity.
    Capron AM
    N Engl J Med; 1999 May; 340(18):1430-4. PubMed ID: 10228198
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical issues in schizophrenia: considerations for treatment and research.
    Dunn LB
    Psychopharmacol Bull; 2007; 40(4):145-55. PubMed ID: 18227784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.